# Commission Implementing Regulation (EU) 2018/670 of 30 April 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances bromuconazole, buprofezin, haloxyfop-P and napropamide (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
(1) in the sixth column, expiration of approval, of row 309, Haloxyfop-P, the date is replaced by ‘31 December 2023’;
(2) in the sixth column, expiration of approval, of row 310, Napropamide, the date is replaced by ‘31 December 2023’;
(3) in the sixth column, expiration of approval, of row 318, Bromuconazole, the date is replaced by ‘31 January 2024’;
(4) in the sixth column, expiration of approval, of row 320, Buprofezin, the date is replaced by ‘31 January 2023’.

---
Source: https://www.legislation.gov.uk/eur/2018/670/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2018-670/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.